Evidence map›Paper›PMID 41404315›Full record

ArticleEFSA journal. European Food Safety Authority2025

In vitro metabolomics approaches to decipher the biochemical and cellular response to genotoxic compounds.

Filipa Amaro, Ester Siniscalchi, Giorgia Maria Varalda, Eleonora Azzinnari, Joana Pinto, Paula Guedes de Pinho, Egidio Iorio, Francesca Marcon

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Filipa AmaroFaculty of Pharmacy University of Porto Porto Portugal.
Ester SiniscalchiItalian Institute of Health (ISS) Rome Italy.
Giorgia Maria VaraldaItalian Institute of Health (ISS) Rome Italy.
Eleonora AzzinnariItalian Institute of Health (ISS) Rome Italy.
Joana PintoFaculty of Pharmacy University of Porto Porto Portugal.
Paula Guedes de PinhoFaculty of Pharmacy University of Porto Porto Portugal.
Egidio IorioItalian Institute of Health (ISS) Rome Italy.
Francesca MarconItalian Institute of Health (ISS) Rome Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New approach methodologies (NAMs) are gaining increasing attention within the scientific community as strategies to reduce the use of animal testing. Their integration into regulatory frameworks for chemical hazard and risk assessment in food and feed would directly support the goals of the European Food Safety Authority (EFSA). Within the framework of the EU-FORA fellowship programme, this study investigated the use of metabolomic approaches to evaluate cellular responses to genotoxic agents, serving as a proof of concept for the development, standardisation and future regulatory application of metabolomics in genotoxicity testing. Human liver-derived cells (HepRG) were exposed to two well-characterised genotoxicants, and both intracellular (endometabolome) and extracellular (exometabolome) metabolites were extracted and analysed using gas chromatography-mass spectrometry (GC-MS). Metabolites associated with energy metabolism, sugar metabolism and antioxidant capacity were identified, and both multivariate and univariate statistical analyses were applied to characterise metabolic profiles. Results obtained under the experimental conditions tested in this pilot study, do not highlight significant differences between exposed and control cultures. Nevertheless, the findings demonstrate the potential of metabolomics to capture biologically relevant pathways, supporting its future application in genotoxicity assessment under alternative experimental conditions and designs.

Indexed as

genotoxicityin vitrometabolomicsnew approach methodologies (NAMs)risk assessment

Identifiers

PMID41404315
PMCPMC12703804

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.